House lawmakers call for transparency, independent review for COVID-19 vaccine program

A trio of Democrats on the House Oversight Committee are asking FDA for more information on how the agency plans to evaluate and deploy COVID-19 vaccines, in an effort to ensure the process is transparent, and involves independent review and interagency cooperation.

The demands for vaccine transparency come as Sichuan Clover Biopharmaceuticals Inc. dosed the first volunteers in a Phase I trial of its COVID-19 vaccine. According to BioCentury’s COVID-19 Resource Center, it is the eighteenth vaccine to enter the clinic...